Technical Analysis for COLL - Collegium Pharmaceutical, Inc.
|Grade||Last Price||% Change||Price Change|
COLL closed up 2.47 percent on Friday, February 23, 2018, on 70 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
|Weak or Absent||Up||Up||Flat|
|See historical COLL trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 23||MACD Bearish Signal Line Cross||Bearish||0.00%|
|Feb 23||Hammer Candlestick||Bullish||0.00%|
|Feb 23||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.00%|
|Feb 23||Wide Bands||Range Expansion||0.00%|
|Feb 22||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||2.47%|
|Feb 22||Wide Bands||Range Expansion||2.47%|
|Feb 22||Down 3 Days in a Row||Weakness||2.47%|
|Feb 21||Stochastic Sell Signal||Bearish||0.00%|
|Feb 21||Wide Bands||Range Expansion||0.00%|
|Feb 21||Overbought Stochastic||Strength||0.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more COLL news...
|52 Week High||26.77|
|52 Week Low||7.37|
|200-Day Moving Average||13.9864|
|50-Day Moving Average||21.267|
|20-Day Moving Average||23.5295|
|10-Day Moving Average||24.513|
|Average True Range||1.7465|
|Chandelier Exit (Long, 3 ATRs )||21.5005|
|Chandelier Exit (Short, 3 ATRs )||24.6095|
|Upper Bollinger Band||26.5797|
|Lower Bollinger Band||20.4793|
|Percent B (%b)||0.66|
|MACD Signal Line||1.038|
|Market Cap||724.38 Million|
|Num Shares||29.6 Million|
|Price-to-Earnings (P/E) Ratio||-6.82|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||27.58|
|Resistance 3 (R3)||27.29||25.97||27.06|
|Resistance 2 (R2)||25.97||25.19||26.12||26.89|
|Resistance 1 (R1)||25.24||24.71||25.61||25.53||26.72|
|Support 1 (S1)||23.19||23.14||23.56||23.48||22.28|
|Support 2 (S2)||21.87||22.66||22.02||22.11|
|Support 3 (S3)||21.14||21.87||21.94|
|Support 4 (S4)||21.43|